Important excerpts from 10k, will post updates as
Post# of 72435
![Avatar](/images/ProfileImages/424989898_3046_Avatar jpeg2.jpg)
Kevetrin, our lead anti-cancer compound, is a small molecule compound that induces activation of p53, a protein involved in controlling cell mutations.
note they state it DOES activate it, not MAY activate it
Other compounds . Independently, and through collaborative relationships with leading universities and institutions supported by funding through government grants, Cellceutix is developing defensin-mimetics for a wide range of indications...
not sure they've said this before
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)